Richard Stephen

Director

Anika Therapeutics, Inc.

US, Bedford [HQ]

CIK 1823843

Data Source

We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.

21,436

Price per Share :

$16.19

Equivalence :

$347,048.84

A

Form 4

21,436 Shares After Transaction

Value : $n/a

$0.0

Transaction Date : 06/08/22
- Footnotes
- Form 4
Footnotes:
#1 These shares represent restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Anika Therapeutics, Inc. common stock. The restricted stock units vest in full on the earlier of the 2023 annual meeting of the Company's stockholders or June 8, 2023.
A

Form 4

33,707 Shares After Transaction

Value : $n/a

$0.0

Transaction Date : 07/09/24
- Footnotes
- Form 4
Footnotes:
#1 These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock. The RSUs vest in full on the earlier of the 2025 annual meeting of the Company's stockholders or July 9, 2025.
A

Form 4

27,936 Shares After Transaction

Value : $n/a

$0.0

Transaction Date : 06/14/23
- Footnotes
- Form 4
Footnotes:
#1 These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock. The RSUs vest in full on the earlier of the 2024 annual meeting of the Company's stockholders or June 14, 2024.